Clinical Trials Directory

Trials / Completed

CompletedNCT03052166

Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging

A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women to Evaluate the Non-inferiority of QT Ultrasound Compared to Digital Mammography-Digital Breast Tomography (DM-DBT)

Status
Completed
Phase
Study type
Observational
Enrollment
755 (actual)
Sponsor
QT Ultrasound LLC · Industry
Sex
Female
Age
18 Years
Healthy volunteers

Summary

Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly moves around the suspended breast to record data for successive sub-volumes of targeted tissue. More than 2000 elements in the curvilinear transducer's array encircle the breast to gather data from the tissue structures of the breast, from nipple to chest wall. Information gathered from this automated QT scan encompasses the entire breast which is currently not commercially available using any other ultrasound technology.

Detailed description

This is a prospective, multicenter, multi-arm case collection study, with IRB approval. The study will follow an adaptive design with an initially planned total enrollment of approximately 600 cases to include both benign and malignant cases, representative of all tissue densities. The images and clinical data accrued in this prospective case collection will be used for creation of a database to facilitate future reader's studies, publications, building teaching files, and future marketing for QT Ultrasound.

Conditions

Interventions

TypeNameDescription
DEVICEQT Ultrasound scanQT Ultrasound scan

Timeline

Start date
2017-04-18
Primary completion
2019-12-31
Completion
2020-01-01
First posted
2017-02-14
Last updated
2021-03-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03052166. Inclusion in this directory is not an endorsement.